Utah Medical Products (UTMD) Operating Expenses (2010 - 2026)

Utah Medical Products' Operating Expenses history runs 17 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 13.92% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $8.9 million, a 8.96% increase from a year earlier, with the FY2025 full-year figure at $8.5 million, down 1.16% from the prior year.
• Operating Expenses improved to $2.7 million in Q1 2026 per UTMD's latest filing, from $772000.0 in the prior quarter.
• Across five years, Operating Expenses topped out at $3.4 million in Q1 2023 and bottomed at $492000.0 in Q4 2024.
• The 5-year median for Operating Expenses is $2.8 million (2024), against an average of $2.6 million.
• Across the five-year window, Operating Expenses plunged 81.03% in 2024 and surged 56.91% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $1.8 million in 2022, then surged by 48.23% to $2.6 million in 2023, then plunged by 81.03% to $492000.0 in 2024, then jumped by 56.91% to $772000.0 in 2025, then surged by 251.94% to $2.7 million in 2026.
• Per Business Quant, the three latest UTMD Operating Expenses figures stand at $2.7 million (Q1 2026), $772000.0 (Q4 2025), and $3.0 million (Q3 2025).